BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers
Journal: Science Translational Medicine
Published: 2020-02-19
DOI: 10.1126/scitranslmed.aax2625
Affiliations: 17
Go to articleJournal: Science Translational Medicine
Published: 2020-02-19
DOI: 10.1126/scitranslmed.aax2625
Affiliations: 17
Go to article